Cargando…

Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study

BACKGROUND: A prominent finding in major depressive disorder (MDD) is distorted stress hormone dynamics, which is regulated by serotonergic brain signaling. An interesting feature of the cerebral serotonin system is the serotonin 4 receptor (5-HT(4)R), which is lower in depressed relative to healthy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vulpius, Gunild M, Köhler-Forsberg, Kristin, Ozenne, Brice, Larsen, Søren V, Nasser, Arafat, Svarer, Claus, Gillings, Nic, Keller, Sune H, Jørgensen, Martin B, Knudsen, Gitte M, Frokjaer, Vibe G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519814/ https://www.ncbi.nlm.nih.gov/pubmed/37542733 http://dx.doi.org/10.1093/ijnp/pyad041

Ejemplares similares

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
por: Rasmussen, Annika Læbo, et al.
Publicado: (2023)

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2022)

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
por: Larsen, Søren Vinther, et al.
Publicado: (2022)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
por: Dam, Vibeke Høyrup, et al.
Publicado: (2022)

Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
por: Dam, V. H., et al.
Publicado: (2021)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2020)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
por: Beliveau, Vincent, et al.
Publicado: (2022)

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
por: Sankar, Anjali, et al.
Publicado: (2023)

Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
por: Armand, Sophia, et al.
Publicado: (2022)

Genetic contributions to brain serotonin transporter levels in healthy adults
por: Bruzzone, Silvia Elisabetta Portis, et al.
Publicado: (2023)

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
por: Larsen, S. V., et al.
Publicado: (2020)

Brain serotonin 4 receptor binding is inversely associated with verbal memory recall
por: Stenbæk, Dea S., et al.
Publicado: (2017)

Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study
por: Hansen, Hanne Demant, et al.
Publicado: (2020)

Common HTR2A variants and 5‐HTTLPR are not associated with human in vivo serotonin 2A receptor levels
por: Spies, Marie, et al.
Publicado: (2020)

Default mode network functional connectivity negatively associated with trait openness to experience
por: Marstrand-Joergensen, Maja Rou, et al.
Publicado: (2021)

BDNF val66met association with serotonin transporter binding in healthy humans
por: Fisher, P M, et al.
Publicado: (2017)

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
por: Sankar, Anjali, et al.
Publicado: (2023)

Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
por: Høgsted, Emma Sofie, et al.
Publicado: (2021)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
por: Hjordt, Liv V., et al.
Publicado: (2020)

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
por: Jorgensen, Anders, et al.
Publicado: (2022)

Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females
por: Tuominen, Lauri, et al.
Publicado: (2017)

Brain Networks Implicated in Seasonal Affective Disorder: A Neuroimaging PET Study of the Serotonin Transporter
por: Nørgaard, Martin, et al.
Publicado: (2017)

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
por: Conradi, Juliane, et al.
Publicado: (2023)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Fat pharms.
por: Ma, M
Publicado: (1996)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Measuring endogenous changes in serotonergic neurotransmission with [(11)C]Cimbi-36 positron emission tomography in humans
por: da Cunha-Bang, Sofi, et al.
Publicado: (2019)

cAMP Signaling in Brain is Decreased in Unmedicated Depressed Patients and Increased by Treatment with a Selective Serotonin Reuptake Inhibitor
por: Fujita, Masahiro, et al.
Publicado: (2016)

Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
por: Sundström Poromaa, Inger, et al.
Publicado: (2019)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
por: Jensen, Kristian Høj Reveles, et al.
Publicado: (2023)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

Effect of Crosslinking Agent Concentration on the Properties of Unmedicated Hydrogels (†)
por: Wong, Rachel Shet Hui, et al.
Publicado: (2015)

No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
por: Stenbæk, Dea Siggaard, et al.
Publicado: (2017)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Cell Engineering and Molecular Pharming for Biopharmaceuticals
por: Abdullah, M.A, et al.
Publicado: (2008)

Introduction of APCs in J. Young Pharm.
por: Mueen, Ahmed KK
Publicado: (2012)

My Vision: J Young Pharm
por: Parasuraman, S
Publicado: (2012)

Pharmacological sex hormone manipulation as a risk model for depression
por: Frokjaer, Vibe G.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ldnf80o8j66aoecad3rk0gp25